Education
About Us
Working with TipRanks
Follow Us
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
Summary of all the Indicators
Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is -3.22, suggesting Jagsonpal Pharmaceuticals Ltd. is a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 203.34, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹198.9, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 210.26, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹198.9, making it a Sell.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points
Classic
197.48
198.42
199.93
200.87
202.38
203.32
204.83
Fibonacci
198.42
199.35
199.93
200.87
201.80
202.38
203.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages
MA5
200.53Sell
200.29Sell
MA10
200.32Sell
201.08Sell
MA20
205.23Sell
203.34Sell
MA50
210.47Sell
210.26Sell
MA100
224.36Sell
218.05Sell
MA200
225.39Sell
222.22Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 201.08, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹198.9, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 218.05, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹198.9, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹198.9 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 210.47, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹198.9 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 224.36, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹198.9 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 225.39, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators
RSI (14)
42.24
Neutral
STOCH (9,6)
61.28
Neutral
STOCHRSI (14)
36.77
Neutral
MACD (12,26)
-3.22
Sell
ADX (14)
16.04
Buy
Williams %R
-53.28
Buy
CCI (14)
-81.80
Neutral
ATR (14)
6.31
-
Ultimate Oscillator
59.35
Neutral
ROC
-5.01
Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 42.24, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 16.04, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is -81.80, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is -5.01, creating a Sell signal.
FAQ
Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Strong Sell.
What is JAGSNPHARM’s RSI (14)?
JAGSNPHARM’s RSI (14) is 42.24, which suggests JAGSNPHARM is a Neutral.
What is JAGSNPHARM’s MACD?
JAGSNPHARM’s MACD is -3.22, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 5-day moving average?
JAGSNPHARM’s 5-day moving average is 200.53, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 20-day moving average?
JAGSNPHARM 20-day moving average is 205.23, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 50-day moving average?
JAGSNPHARM’s 50-day moving average is 210.47, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 200-day moving average?
JAGSNPHARM’s 200-day moving average is 225.39, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s Williams % R (14)?
JAGSNPHARM’s Williams % R (14) is -53.28, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s CCI (14)?
JAGSNPHARM’s CCI (14) is -81.80, which suggests JAGSNPHARM is a Neutral.
What is the share price of Jagsonpal Pharmaceuticals Ltd.?